The overall dietary pattern matters more than any single nutrient
Trusted for over 90 years
While formulations differ in dosing frequency, onset, and tolerability, they show broadly comparable safety and efficacy
Back to Journals Diabetes, Metabolic Syndrome and Obesity Volume 19 Gastrointestinal Adverse Effects of GLP-1 and Dual GLP-1/GIP Receptor Agonists: A Comprehensive Update in Diabetic and Obese Populations Authors Ylmaz N , Bastemir M Received 27 November 2025 Accepted for publication 13 January 2026 Published 30 January 2026 Volume 2026:19 584175 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 4 Editor who approved publication: Dr Halis Akturk Nimet Ylmaz, 1 Mehmet Bastemir 2 1 Department of Gastroenterology, SANKO University Faculty of Medicine, Gaziantep, Turkey
- , BPC 157
Growth hormone therapy can cause certain side effects, like: If a child has diabetes, it could make the blood sugar higher, but it doesnt cause diabetes, stresses Dr